Jia Y - Search Results

1

Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Wang Q, Jiao L, Wang S, Chen P, Bi L, Zhou D, Yao J, Li J, Wang L, Chen Z, Jia Y, Zhang Z, Shen W, Zhu W, Xu J, Gao Y, Xu L, Gong Y. Wang Q, et al. Among authors: jia y. Biol Proced Online. 2020 Mar 1;22:5. doi: 10.1186/s12575-020-00117-5. eCollection 2020. Biol Proced Online. 2020. PMID: 32140080 Free PMC article.

2

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial.

Wang Q, Jiao L, Wang S, Chen P, Bi L, Zhou D, Yao J, Li J, Chen Z, Jia Y, Zhang Z, Shen W, Zhu W, Xu J, Gao Y, Gong Y, Xu L. Wang Q, et al. Among authors: jia y. Front Pharmacol. 2018 Nov 6;9:1233. doi: 10.3389/fphar.2018.01233. eCollection 2018. Front Pharmacol. 2018. PMID: 30459612 Free PMC article.

3

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Jiao L, Xu J, Sun J, Chen Z, Gong Y, Bi L, Lu Y, Yao J, Zhu W, Hou A, Feng G, Jia Y, Shen W, Li Y, Zhang Z, Chen P, Xu L. Jiao L, et al. Among authors: jia y. Front Pharmacol. 2019 Jul 2;10:732. doi: 10.3389/fphar.2019.00732. eCollection 2019. Front Pharmacol. 2019. PMID: 31333456 Free PMC article.

4

Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer.

Li H, Duan Z, Zhao C, Fang W, Jia Y, Li X, Kong F, Zhao L. Li H, et al. Among authors: jia y. Cancer Manag Res. 2020 Sep 9;12:8209-8220. doi: 10.2147/CMAR.S267694. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982417 Free PMC article.

5

Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial.

Zhang Y, Guo S, Wang C, Liu X, Liu Y, Shang H, Yang P, Wang L, Zhai J, Li X, Jia Y. Zhang Y, et al. Among authors: jia y. Trials. 2022 Jan 4;23(1):9. doi: 10.1186/s13063-021-05805-5. Trials. 2022. PMID: 34983588 Free PMC article.

6

Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis.

Xiao X, Zhang G, Sun B, Wang C, Wang X, Kong F, Jia Y. Xiao X, et al. Among authors: jia y. Transl Cancer Res. 2022 Jun;11(6):1472-1482. doi: 10.21037/tcr-22-71. Transl Cancer Res. 2022. PMID: 35836506 Free PMC article.

7

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.

Kong F, Gao F, Chen J, Sun Y, Zhang Y, Liu H, Li X, Yang P, Zheng R, Liu G, Jia Y. Kong F, et al. Among authors: jia y. Oncotarget. 2016 Aug 30;7(35):56193-56199. doi: 10.18632/oncotarget.10907. Oncotarget. 2016. PMID: 27486880 Free PMC article.

8

Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Sun Y, Zhang Y, Ren S, Li X, Yang P, Zhu J, Lin L, Wang Z, Jia Y. Sun Y, et al. Among authors: jia y. Int Immunopharmacol. 2020 Jun;83:106454. doi: 10.1016/j.intimp.2020.106454. Epub 2020 Apr 4. Int Immunopharmacol. 2020. PMID: 32259700

9

The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer.

Xia Y, Li W, Li Y, Liu Y, Ye S, Liu A, Yu J, Jia Y, Liu X, Chen H, Guo Y. Xia Y, et al. Among authors: jia y. Transl Oncol. 2020 Dec;13(12):100849. doi: 10.1016/j.tranon.2020.100849. Epub 2020 Aug 28. Transl Oncol. 2020. PMID: 32866935 Free PMC article.

10

Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis.

Kong F, Wang C, Li X, Jia Y. Kong F, et al. Among authors: jia y. Front Pharmacol. 2021 Sep 13;12:739843. doi: 10.3389/fphar.2021.739843. eCollection 2021. Front Pharmacol. 2021. PMID: 34588988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,273 results

Search Page

Filters